Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus

Journal of Virology

Volumn 79, Issue 12, 2005, Pages 7845-7851

  Stittelaar, Koert J ^a   Van Amerongen, Geert ^b   Kondova, Ivanela ^c   Kuiken, Thijs ^a   Van Lavieren, Rob F ^d   Pistoor, Frank H M ^d   Niesters, Hubert G M ^a   Van Doornum, Gerard ^a   Van Der Zeijst, Ben A M ^b   Mateo, Luis ^e   Chaplin, Paul J ^e   Osterhaus, Albert D M E ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NETHERLANDS VACCINE INSTITUTE   (Netherlands)

^c BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^d ViroClinics BV   (Netherlands)

^e Bavarian Nordic GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ELSTREE RIVM; SMALLPOX VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNIZATION; MACACA; MODIFIED VACCINIA VIRUS ANKARA; MONKEYPOX VIRUS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROVOCATION TEST; QUANTITATIVE ANALYSIS; RESPIRATORY TRACT INFECTION; VACCINIA VIRUS; VIRUS DETECTION; VIRUS INFECTION; VIRUS ISOLATION; VIRUS LOAD; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALS; ANTIBODIES, VIRAL; DISEASE MODELS, ANIMAL; HUMANS; IMMUNIZATION; LUNG; MACACA FASCICULARIS; MONKEYPOX; MONKEYPOX VIRUS; RESPIRATORY TRACT INFECTIONS; SKIN; SMALLPOX VACCINE; T-LYMPHOCYTES; VACCINIA VIRUS;

ANIMALIA; ANKARA; MACACA; MONKEYPOX VIRUS; VACCINIA; VACCINIA VIRUS; VARIOLA VIRUS;

EID: 19944418821     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.12.7845-7851.2005     Document Type: Article

References (24)

1. Amorosa, V. K., and S. N. Isaacs. 2003. Separate worlds set to collide: smallpox, vaccinia virus vaccination, and human immunodeficiency virus and acquired immunodeficiency syndrome. Clin. Infect. Dis. 37:426-432.
2. Bray, M., and M. E. Wright. 2003. Progressive vaccinia. Clin. Infect. Dis. 36: 766-774.
3. Breman, J. G., and I. Arita. 1980. The confirmation and maintenance of smallpox eradication. N. Engl. J. Med. 303:1263-1273.
4. Drexler, I., K. Heller, B. Wahren, V. Erfle, and G. Sutter. 1998. Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells. J. Gen. Virol. 79:347-352.
5. Earl, P. L., J. L. Americo, L. S. Wyatt, L. A. Eller, J. C. Whitbeck, G. H. Cohen, R. J. Eisenberg, C. J. Hartmann, D. L. Jackson, D. A. Kulesh, M. J. Martinez, D. M. Miller, E. M. Mucker, J. D. Shamblin, S. H. Zwiers, J. W. Huggins, P. B. Jahrling, and B. Moss. 2004. Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox. Nature 428:182-185.
6. Espy, M. J., F. R. Cockerill III, R. F. Meyer, M. D. Bowen, G. A. Poland, T. L. Hadfield, and T. F. Smith. 2002. Detection of smallpox virus DNA by LightCycler PCR. J. Clin. Microbiol. 40:1985-1988.
7. Franchini, M., H. Hefti, S. Vollstedt, B. Glanzmann, M. Riesen, M. Ackermann, P. Chaplin, K. Shortman, and M. Suter. 2004. Dendritic cells from mice neonatally vaccinated with modified vaccinia virus Ankara transfer resistance against herpes simplex virus type I to naive one-week-old mice. J. Immunol. 172:6304-6312.
8. Grabenstein, J. D., and W. Winkenwerder, Jr. 2003. US military smallpox vaccination program experience. JAMA 289:3278-3282.
9. Henderson, D. A., T. V. Inglesby, J. G. Bartlett, M. S. Ascher, E. Eitzen, P. B. Jahrling, J. Hauer, M. Layton, J. McDade, M. T. Osterholm, T. O'Toole, G. Parker, T. Perl, P. K. Russell, and K. Tonat. 1999. Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 281:2127-2137.
10. Kemper, A. R., M. M. Davis, and G. L. Freed. 2002. Expected adverse events in a mass smallpox vaccination campaign. Eff. Clin. Pract. 5:84-90.
11. Kuiken, T., R. A. Fouchier, M. Schutten, G. F. Rimmelzwaan, G. van Amerongen, D. van Riel, J. D. Laman, T. de Jong, G. van Doornum, W. Lim, A. E. Ling, P. K. Chan, J. S. Tam, M. C. Zambon, R. Gopal, C. Drosten, S. van der Werf, N. Escriou, J. C. Manuguerra, K. Stohr, J. S. Peiris, and A. D. Osterhaus. 2003. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 362:263-270.
12. Lane, J. M., F. L. Ruben, E. Abrutyn, and J. D. Millar. 1970. Deaths attributable to smallpox vaccination, 1959 to 1966, and 1968. JAMA 212: 441-444.
13. Lewis-Jones, S. 2004. Zoonotic poxvirus infections in humans. Curr. Opin. Infect. Dis. 17:81-89.
14. Mayr, A. 2003. Smallpox vaccination and bioterrorism with pox viruses. Comp. Immunol. Microbiol. Infect. Dis. 26:423-430.
15. Mayr, A., H. Stickl, H. K. Muller, K. Danner, and H. Singer. 1978. The smallpox vaccination strain MVA: marker, genetic structure, experience gained with the parenteral vaccination and behavior in organisms with a debilitated defence mechanism. Zentbl. Bakteriol. B 167:375-390.
16. Meyer, H., M. Perrichot, M. Stemmler, P. Emmerich, H. Schmitz, F. Varaine, R. Shungu, F. Tshioko, and P. Formenty. 2002. Outbreaks of disease suspected of being due to human monkeypox virus infection in the Democratic Republic of Congo in 2001. J. Clin. Microbiol. 40:2919-2921.
17. Niesters, H. G. 2002. Clinical virology in real time. J. Clin. Virol. 25(Suppl.): 3-12.
18. Rosenthal, S. R., and J. C. Clifford. 2002. Development of vaccines for bio-warfare agents. Dev. Biol. (Basel) 110:99-105.
19. Stickl, H., V. Hochstein-Mintzel, A. Mayr, H. C. Huber, H. Schafer, and A. Holzner. 1974. MVA vaccination against smallpox: clinical tests with an attenuated live vaccinia virus strain (MVA). Dtsch. Med. Wochenschr. 99: 2386-2392.
20. Stittelaar, K. J., T. Kuiken, R. L. de Swart, G. van Amerongen, H. W. Vos, H. G. Niesters, P. van Schalkwijk, K. T. van der, L. S. Wyatt, B. Moss, and A. D. Osterhaus. 2001. Safety of modified vaccinia virus Ankara (MVA) in immune-suppressed macaques. Vaccine 19:3700-3709.
21. Stittelaar, K. J., L. S. Wyatt, R. L. de Swart, H. W. Vos, J. Groen, G. van Amerongen, R. S. van Binnendijk, S. Rozenblatt, B. Moss, and A. D. Osterhaus. 2000. Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies. J. Virol. 74:4236-4243.
22. Sutter, G., and B. Moss. 1992. Nonreplicating vaccinia vector efficiently expresses recombinant genes. Proc. Natl. Acad. Sci. USA 89:10847-10851.
23. Wyatt, L. S., P. L. Earl, L. A. Eller, and B. Moss. 2004. Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge. Proc. Natl. Acad. Sci. USA 101:4590-4595.
24. Zaucha, G. M., P. B. Jahrling, T. W. Geisbert, J. R. Swearengen, and L. Hensley. 2001. The pathology of experimental aerosolized monkeypox virus infection in cynomolgus monkeys (Macaca fascicularis). Lab. Investig. 81: 1581-1600.